-
Q-State, LUCA Biologics, AskBio, And More: News From August 2019
Aug 29, 2019, 10:45 AM by Michael CroftFull storyBio-IT World | August featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Q-State, LUCA Biologics, AskBio, and more.
-
IDBS achieves SOC 2 compliance
Aug 29, 2019, 04:40 AM by Michael CroftLONDON, UNITED KINGDOM - Aug 29, 2019 - Boston, US and Guildford, UK - 29 August 2019 - IDBS has achieved compliance with SOC 2, following an audit by CyberGuard Compliance, LLC to the American Institute of Certified Public Accountants' (AICPA) Trust Services CriteriaFull story -
Cardiovascular Disease Related Peptides Are Now Accessible at Creative Peptides
Aug 29, 2019, 01:42 AM by Michael CroftNEW YORK, NY - Aug 29, 2019 - Having been dedicated to the great cause of supplying peptides for nearly two decades, the New York-based brand Creative Peptides recently adds another major peptide category for scientists who are involved with cardiovascular disease researchFull story -
Creative Enzymes Upgrades Its Enzymes Products for Research and Industrial Use
Aug 29, 2019, 00:03 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Aug 29, 2019 - Creative Enzymes, a professional enzymes provider located in New York, always hammers at researches and trials in order to provide customers with various enzymes as many as possibleFull story -
BOC Sciences Is Leading Drug Discovery and Process R & D
Aug 28, 2019, 23:35 PM by Michael CroftSHIRLEY, NY - Aug 29, 2019 - Starting from a chemical vendor in 2007, BOC Sciences has now become a well-established brand and is currently leading drug discovery and process R&D, in an attempt to help researchers engaged in this field to find a more efficient and cost-effective approach to early drug developmentFull story -
NIH Announces Genomic Innovator Awards Winners
Aug 28, 2019, 10:55 AM by Michael CroftBio-IT World | The National Human Genome Research Institute announced the winners of their Genomic Innovator Awards. Researchers from the University of Nebraska Medical Center, Omaha; Vanderbilt University Medical Center; Harvard Medical School, Boston; Massachusetts General Hospital, Boston; The City of Hope Comprehensive Cancer Center, Duarte, California; and the University of Maryland-Baltimore were honored.Full story -
HiFiBiO Therapeutics Closes $67 Million Series C Financing to Build on Recent Success and Advance Pipeline of Novel Antibody Drugs for Cancer and Autoimmune Disorders
Aug 28, 2019, 09:38 AM by Michael CroftCAMBRIDGE,, MA, UNITED STATES - Aug 28, 2019 - HiFiBiO Therapeutics, a pioneer in innovative biotherapeutics with a unique single-cell analytics platform for extensive immune profiling, today announced the completion of a $67 Million Series C financing roundFull story -
Creative Enzymes Has Upgraded Mature Enzyme Services to Accelerate Your Enzymes Discovery Process
Aug 28, 2019, 05:09 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Aug 28, 2019 - As an excellent supplier and manufacturer, Creative Enzymes recently has upgraded three enzymes related services, including biocatalysis service, enzyme labelling service, and enzyme modification service for researchers to accelerate your enzyme discovery processFull story -
Grant Awarded to MDI Biological Laboratory Scientist James A. Coffman, Ph.D.
Aug 27, 2019, 11:37 AM by Michael CroftBAR HARBOR, ME, UNITED STATES - Aug 27, 2019 - The MDI Biological Laboratory has announced that James A. Coffman, Ph.D., has received a two-year grant totaling $166,000 from the National Institutes of Health (NIH) for his research on the regulation of cortisol, a naturally occurring steroid that governs how the body responds to stressFull story -
Baptist Health South Florida Launches New Online Patient Access Experience for Consumers With Technology from Kyruus
Aug 27, 2019, 10:43 AM by Michael CroftBOSTON, MA, UNITED STATES - Aug 27, 2019 - Leading Florida Health System Enhances Digital Capabilities for Both English- and Spanish-Speaking Consumers in the Greater Miami AreaBoston, MA - August 27, 2019 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that Baptist Health South Florida, the most-awarded health system in South Florida by UFull story -
Sterling commences large-scale production of Nanologica’s silica particles
Aug 27, 2019, 09:46 AM by Michael Croft, UNITED KINGDOM - Aug 27, 2019 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions has started large-scale production of Nanologicas silica particlesFull story -
WCG Introduces Velos eResearch eXpress™
Aug 27, 2019, 08:18 AM by Michael CroftPRINCETON, NJ - Aug 27, 2019 - The WIRB-Copernicus Group®s (WCG) Clinical Services Division introduces Velos eResearch eXpress, an out-of-the-box, cloud-based solution that enables clinical research sites to centralize and manage their research activities on a single, automated technology platformFull story -
Microway Provides Vyasa Analytics With NVIDIA DGX-1, NumberSmasher GPU Server
Aug 26, 2019, 15:15 PM by Michael CroftFull storyBio-IT World Brief | Microway announced it has provided an NVIDIA DGX-1 supercomputer and Microway NumberSmasher Tesla GPU Server to Vyasa Analytics.
-
Researchers Beginning To Use CRISPR In Studies
Aug 26, 2019, 15:05 PM by Michael CroftFull storyBio-IT World | After years of discussion, patent lawsuits, and hype, the gene-editing tool know as CRISPR is finally making its way into clinical trials.
-
The Next Trick For CRISPR Is Gene-Editing Pain Away
Aug 23, 2019, 09:35 AM by Michael CroftFull storyMIT Technology Review | A family of street performers could walk on coals. Scientists have paired the discovery with the gene-editing tool CRISPR, in what they say is a step toward a gene therapy that could block severe pain caused by diabetes, cancer, or car accidents without the addictive effects of opioids.
-
Microway Provides Vyasa Analytics NVIDIA® DGX-1™ and NumberSmasher® GPU Server
Aug 21, 2019, 12:22 PM by Michael CroftPLYMOUTH, MA - Aug 21, 2019 - Microway, a leading provider of computational clusters, servers, and workstations for AI and HPC applications, announces it has provided an NVIDIA® DGX-1 supercomputer and Microway NumberSmasher® Tesla® GPU Server to deep-learning leader Vyasa AnalyticsFull story -
Color Receives Genetic Counseling Grant for All of Us
Aug 21, 2019, 11:20 AM by Michael CroftBio-IT World | The All of Us research program has awarded $4.6 million in initial funding to Color, a health technology company in Burlingame, California, to establish the program’s nationwide genetic counseling resource. Through this funding, Color’s network of genetic counselors will help participants understand what the genomic testing results mean for their health and their families.Full story -
Signant Health Appoints Todd Everhart as Clinical Vice President to Accelerate Intelligent eCOA and Predictive Data Analytics in Medical Clinical Research
Aug 20, 2019, 10:27 AM by Michael CroftPHILADELPHIA, PA, UNITED STATES - Aug 20, 2019 - Signant Health, formerly CRF Health and Bracket, has appointed Anthony Todd Everhart, MD, FACP to the Signant Health Science and Medicine Team as Clinical Vice President, Internal Medicine, reporting to the Chief Medical Officer, DrFull story -
Creative Diagnostics Introduces New Lyophilized Exosomes for Research
Aug 20, 2019, 04:18 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Aug 20, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics announces that it has developed lyophilized exosomes for global researchers, which are isolated from different biological sources including human biofluids of certified healthy donors (plasma, serum, urine, saliva) and different cell culture supernatantFull story -
Knopp Biosciences Announces Start of Phase 2 Clinical Trial Evaluating Oral Dexpramipexole in Moderate-to-Severe Eosinophilic Asthma
Aug 19, 2019, 14:56 PM by Michael CroftPITTSBURGH, PA - Aug 19, 2019 - Knopp Biosciences LLC today announced the start of Phase 2 dose-ranging clinical trial in moderate-to-severe eosinophilic asthmaFull story